Elucidating the material basis and potential mechanisms of Ershiwuwei Lvxue Pill acting on rheumatoid arthritis by UPLC-Q-TOF/MS and network pharmacology
- PMID: 35130279
- PMCID: PMC8820630
- DOI: 10.1371/journal.pone.0262469
Elucidating the material basis and potential mechanisms of Ershiwuwei Lvxue Pill acting on rheumatoid arthritis by UPLC-Q-TOF/MS and network pharmacology
Abstract
Ershiwuwei Lvxue Pill (ELP, མགྲིན་མཚལ་ཉེར་ལྔ།), a traditional Tibetan medicine preparation, has been used hundreds of years for the clinical treatment of rheumatoid arthritis (RA) in the highland region of Tibet, China. Nevertheless, its chemical composition and therapeutic mechanism are unclear. This study aimed to uncover the potentially effective components of ELP and the pharmacological mechanisms against RA by combing UPLC-Q-TOF/MS and network pharmacology. In this study, 96 compounds of ELP were identified or tentatively characterized based on UPLC-Q-TOF/MS analysis. Then, a total of 22 potential bioactive compounds were screened by TCMSP with oral bioavailability and drug-likeness. Preliminarily, 10 crucial targets may be associated with RA through protein-protein interaction network analysis. The functional enrichment analysis indicated that ELP exerted anti-RA effects probably by synergistically regulating many biological pathways, such as PI3K-Akt, Cytokine-cytokine receptor interaction, JAK-STAT, MAPK, TNF, and Toll-like receptor signaling pathway. In addition, good molecular docking scores were highlighted between five promising bioactive compounds (ellagic acid, quercetin, kaempferol, galangin, coptisine) and five core targets (PTGS2, STAT3, VEGFA, MAPK3, TNF). Overall, ELP can exert its anti-RA activity via multicomponent, multitarget, and multichannel mechanisms of action. However, further studies are needed to validate the biological processes and effect pathways of ELP.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Tibetan medicine Ershiwuwei Lvxue Pill attenuates collagen-induced arthritis via inhibition of JAK2/STAT3 signaling pathway.J Ethnopharmacol. 2021 Apr 24;270:113820. doi: 10.1016/j.jep.2021.113820. Epub 2021 Jan 16. J Ethnopharmacol. 2021. PMID: 33465441
-
Ershiwuwei Lvxue Pill alleviates rheumatoid arthritis by different pathways and produces changes in the gut microbiota.Phytomedicine. 2022 Dec;107:154462. doi: 10.1016/j.phymed.2022.154462. Epub 2022 Sep 17. Phytomedicine. 2022. PMID: 36162242
-
Exploring the mechanism of Sendeng-4 against rheumacid arthritis through integrated serum pharmacochemistry, transcriptomics, and network pharmacology.Biomed Chromatogr. 2024 Aug;38(8):e5893. doi: 10.1002/bmc.5893. Epub 2024 Jun 10. Biomed Chromatogr. 2024. PMID: 38853700
-
Integrating network pharmacology and pharmacological evaluation to explore the protective mechanism of Ershiwuwei Zhenzhu pill in ischemic stroke.J Ethnopharmacol. 2023 Jan 30;301:115847. doi: 10.1016/j.jep.2022.115847. Epub 2022 Oct 19. J Ethnopharmacol. 2023. PMID: 36272491
-
Integrated strategy of LC-MS and network pharmacology for predicting active constituents and pharmacological mechanisms of Ranunculus japonicus Thunb. for treating rheumatoid arthritis.J Ethnopharmacol. 2021 May 10;271:113818. doi: 10.1016/j.jep.2021.113818. Epub 2021 Jan 16. J Ethnopharmacol. 2021. PMID: 33465444
Cited by
-
Integrating Network Pharmacology and Molecular Docking Approach to Elucidate the Mechanism of Commiphora wightii for the Treatment of Rheumatoid Arthritis.Bioinform Biol Insights. 2024 May 18;18:11779322241247634. doi: 10.1177/11779322241247634. eCollection 2024. Bioinform Biol Insights. 2024. PMID: 38765022 Free PMC article.
-
Preliminary Exploration of Potential Active Ingredients and Molecular Mechanisms of Yanggan Yishui Granules for Treating Hypertensive Nephropathy Using UPLC-Q-TOF/MS Coupled with Network Pharmacology and Molecular Docking Strategy.J Anal Methods Chem. 2024 May 10;2024:7967999. doi: 10.1155/2024/7967999. eCollection 2024. J Anal Methods Chem. 2024. PMID: 38766523 Free PMC article.
-
Integrative medicine using East Asian herbal medicine for inflammatory pain in patients with rheumatoid arthritis: A protocol for systematic review and meta-analysis integrated with multiple data mining for core candidate discovery.Medicine (Baltimore). 2023 Jun 9;102(23):e33903. doi: 10.1097/MD.0000000000033903. Medicine (Baltimore). 2023. PMID: 37335629 Free PMC article.
References
-
- Ministry of Health of the People’s Republic of China, Drug Standard of Ministry of Public Health of the Peoples Republic of China, People’s Medical Publishing House, Beijing, 1995.
-
- Ma JC, Xiawu LX. Observation on the curative effect of Tibetan medicine twenty-five tastes donkey blood pills in treating gout. World Latest Medicine Information. 2019; 19(25):145.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous